Various endocrine therapy strategies, including SERD, SERM, AI, GnRHa, and inhibitors of PI3K, AKT, mTOR, and CDK4/6, are being explored to enhance the immune response in breast cancer (146). Here, MTOR is linked to breast carcinoma.